Bristol-Myers to Pay $11 Billion to License Cancer Drug
Prior: P: 235.7
New: N: -
Prior: Prior: 235.7
New: New: -
-
Prior: Prior: 6.98
New: New: -
Prior: Prior: 49
New: New: -
Latest News
- CoreWeave Stock Soars on $7B Data Center Deal With Applied Digital
- CrowdStrike forecasts downbeat second-quarter revenue, shares fall
- Hewlett Packard beats Q2 results estimates on AI demand; records $1.36 billion charge
- Tariff uncertainty is hammering one of America's favorite food escapes — snacks
- China's rare earth export curbs hit the auto industry worldwide
- Analyst Report: Crowdstrike Holdings Inc